Are Cbd Companies An Asset To Your Marijuana Stock Portfolio?

A great deal of progress is being made on learning how marijuana’s chemical cannabinoids can be used as medicine, and among the most interesting of these marijuana compounds is cannabidiol their wise known as CBD. It’s one of at least 113 active cannabinoids found in marijuana, it’s not responsible for marijuana’s psychoactive effect, and it accounts for about 40% of the marijuana plant’s extract. At the forefront of research into CBD’s use as a medicine is GW Pharmaceuticals (NASDAQ: GWPH), a U.K. drug developer that currently markets a tetrahydrocannabinol (THC)-derived drug in Europe for the treatment of muscle spasms in multiple sclerosis patients. Is CBD The True Medical Catalyst Of Marijuana? GW Pharmaceuticals recorded data from three separate scientifically controlled tests this past year identifying that its purified CBD, Epidiolex, reduces seizures by about 40% in patients with rare forms of childhood-onset epilepsy, including Dravet syndrome and Lennox-Gastaut syndrome....



See Article on Marijuana Stocks HERE